Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00711204
Recruitment Status : Withdrawn (No patients were enrolled in the study.)
First Posted : July 8, 2008
Last Update Posted : December 10, 2012
Sponsor:
Collaborator:
Pfizer
Information provided by:
Eisai Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : June 2009
Study Completion Date : No date given